Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

New drug candidates for depression - a nationwide population-based study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. One-Year Follow-up on Liraglutide Treatment for Prediabetes and Overweight/Obesity in Clozapine- or Olanzapine-Treated Patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Mortality in unipolar depression preceding and following chronic somatic diseases

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Neural correlates of improved recognition of happy faces after erythropoietin treatment in bipolar disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Electroconvulsive therapy increases brain volume in major depression: a systematic review and meta-analysis

    Research output: Contribution to journalReviewResearchpeer-review

  1. Hair cortisol in newly diagnosed bipolar disorder and unaffected first-degree relatives

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Metabolic profile in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Smartphone-based self-monitoring in bipolar disorder: evaluation of usability and feasibility of two systems

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Neural response during emotion regulation in monozygotic twins at high familial risk of affective disorders

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: To investigate whether continued use of non-aspirin NSAID, low-dose aspirin, high-dose aspirin, statins, allopurinol and angiotensin agents decreases the rate of incident depression using Danish nationwide population-based registers.

METHODS: All persons in Denmark who purchased the exposure medications of interest between 1995 and 2015 and a random sample of 30% of the Danish population was included in the study. Two different outcome measures were included, (i) a diagnosis of depressive disorder at a psychiatric hospital as in-patient or out-patient and (ii) a combined measure of a diagnosis of depression or use of antidepressants.

RESULTS: A total of 1 576 253 subjects were exposed to one of the six drugs of interest during the exposure period from 2005 to 2015. Continued use of low-dose aspirin, statins, allopurinol and angiotensin agents was associated with a decreased rate of incident depression according to both outcome measures. Continued uses of non-aspirin NSAIDs as well as high-dose aspirin were associated with an increased rate of incident depression.

CONCLUSION: The findings support the potential of agents acting on inflammation and the stress response system in depression as well as the potential of population-based registers to systematically identify drugs with repurposing potential.

Original languageEnglish
JournalActa Psychiatrica Scandinavica
Volume139
Issue number1
Pages (from-to)68-77
Number of pages10
ISSN0001-690X
DOIs
Publication statusPublished - Jan 2019

ID: 56121007